ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus...
Choco Up Introduces AI-Powered Credit Assessment Engine to Drive SME Growth
Through holistic AI adoption, Choco Up now reduces funding timelines from days to hours, giving SMEs rapid access to capital. SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- Choco Up, Asia's leading growth financing platform, has unveiled a new Artificial...
Indonesia's Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership
BANDUNG, Indonesia, Oct. 25, 2025 /PRNewswire/ -- Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers' Network (DCVMN), working to ensure equitable access to safe,...
Former UN Secretary-General Commends AiMOGA Robotics: When Eastern Courtesy Meets the Intelligent Future
WUHU, China, Oct. 24, 2025 /PRNewswire/ -- As autumn deepens and the fragrance of osmanthus fills the air, the riverside city of Wuhu welcomed a distinguished guest — Mr. Ban Ki-moon, former UN Secretary-General Ban Ki-moon. In his capacity as Chery...
Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania's Green Future
As Shanghai Electric's fourth photovoltaic project in Romania, this initiative marks a major step forward for the country's clean energy sector. SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) celebrated a major...
Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection
BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016...
China Brings Connected Vehicles to Life in Shanghai: Advancing C-V2X Deployment including 5G-Advanced
SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- In Jiading, Shanghai, the 5G Automotive Association (5GAA) and Shanghai International Automobile City (SIAC) co-hosted the "C-V2X Implementation in China and International Cooperation" Conference. The full-day...
Geely Debuts EX5 in the UK, Driving Its Expansion into Europe's Rapidly-Growing EV Segment
LONDON, Oct. 24, 2025 /PRNewswire/ -- Geely Auto today officially launched the Geely EX5, an award-winning all-electric SUV, in the United Kingdom. This launch reinforces Geely Auto's commitment to sustainable mobility and its ambition to become a...
Ping An Bank Upgraded to AA in MSCI ESG Ratings, Demonstrating Outstanding Achievements in Sustainable Development
HONG KONG and SHANGHAI, Oct. 23, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318 / 82318; SSE: 601318) is pleased to announce that its subsidiary, Ping An Bank (the "Bank",...
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease
TAIPEI, Oct. 23, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and...